 |
| Asthma Screener |
|
 |
|
Does your child sometimes
have difficulty breathing?
Take this test—it could change your child's life |
|
| Asthma basics |
|
- Asthma is a chronic disease of
the lungs that makes breathing
difficult
- In most children, asthma
develops before 5 years of age1
- Although asthma can't be cured,
it can be controlled with treatment,
and children with the disease
can live normal, active lives
- Many children with asthma don't
get the treatment they need
|
|
| Does your child: |
|
- Cough or have trouble breathing when walking, running, or playing?
- Get tired or fatigued easily when playing?
- Wake up at night coughing or having difficulty breathing?
- Complain of pain or tightness in the chest?
- Sometimes make wheezing sounds?
- Avoid taking part in sports or other social activities that require physical exertion?
|
|
| Are your child's breathing
problems worse when: |
|
- Outdoors in cold weather?
- Around cigarette smoke, dust, or pets?
|
|
| Has either parent been diagnosed
with asthma or other allergic disease? |
|
IF YOU'VE ANSWERED YES TO ONE OR MORE OF THESE QUESTIONS,
PLEASE SPEAK WITH YOUR DOCTOR TODAY ABOUT EVALUATING
YOUR CHILD FOR ASTHMA. |
|
| What will happen
if my child is diagnosed with asthma?
|
|
- Your doctor will work with
you to develop a plan to manage
your child's condition
- The plan will include
ongoing monitoring of the
child's asthma, control of the
factors (dust, pollen, smoke,
cold weather, etc.) that
trigger asthma symptoms, and
medications to prevent and treat
asthma symptoms
|
|
|
| AccuNeb® (albuterol sulfate) Inhalation Solution is indicated for the relief of bronchospasm in patients 2 to 12 years of age with asthma (reversible obstructive airway disease). |
 |
| Important Safety Information |
|
| In a clinical trial with AccuNeb® Inhalation Solution 0.63 mg, AccuNeb® Inhalation Solution 1.25 mg, and placebo, the most commonly reported adverse events were asthma exacerbations (11.1%, 13%, 8.5%), otitis media (0.9%, 4.3%, 0%), allergic reaction (3.4%, 0.9%, 1.7%), gastroenteritis (3.4%, 0.9%, 0.9%), and flu syndrome (2.6%, 2.6%, 1.7%). |
|
| Like other beta-adrenergic agonists, AccuNeb® Inhalation Solution can produce paradoxical bronchospasm, which may be life-threatening. AccuNeb® Inhalation Solution should be used with caution in patients with cardiovascular disorders and patients being treated with epinephrine, oral sympathomimetics, beta-blockers, MAOIs, or tricyclic antidepressants. |
|
| Please see Patient Prescribing Information. |
|
|
|
|
|
|
|
|
|
